NTRK1 and non-small cell lung carcinoma: The molecular screening of NSCLC is vital to guiding the most appropriate therapies, with studies reporting the dysregulation of several receptor tyrosine kinases (RTK) as common tumorigenic mechanisms in NSCLC [46,47,48].